Our technology is aimed at helping people with severe vision loss due to:
To benefit from this technology people will need:
- Some remaining retinal ganglion cells
- A healthy optic nerve and visual cortex
- Very low or no vision
- To have been able to see in the past, so that the vision processing part of the brain has developed fully.
Why these conditions?
Retinitis pigmentosa (RP) and age-related macular degeneration (AMD) are two major causes of blindness and low vision in Australia and worldwide. Both these conditions lead to damage of the photoreceptor cells in the retina that are crucial to vision, but leave the optic nerve and visual cortex healthy and intact.
Our approach takes advantage of the healthy parts of the visual system to maximise the benefits for people with RP and AMD.
We hope that with more time and research this technology will be able to assist people with other conditions that lead to blindness or low vision.
Monash Vision Group
The Monash Vision Group (MVG) is another group in Australia developing a bionic eye. This device will work in a different way, with an implant placed directly on the visual cortex of the brain. This approach bypasses the retina and optic nerve, making the MVG device suitable for people with vision loss due to:
- Diabetic retinopathy
- Macular degeneration, and
Find out more about who the MVG bionic eye can help on their website.